Lupus Science & Medicine® is a global, peer reviewed, open access online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all …

Jul 26, 2024 · Objective To obtain updated estimates on the incidence and prevalence of systemic lupus erythematosus (SLE) in the UK, over the period 1990–2020, using the Clinical Practice …

LiH, et≤al Lupus Science Medicine 202512e001400 doi101136lupus-2024-001400 1 Postmarketing safety evaluation of belimumab: a pharmacovigilance analysis Huqun Li,1 …

AdelhelmfiBH, etfial Lupus Science Medicine 202310e001018 doi101136lupus2023001018 1 Therapy with direct oral anticoagulants for secondary prevention of thromboembolic events in …

Jan 4, 2025 · Objective Black people in the USA have a higher incidence and severity of SLE and worse outcomes, yet they are significantly under-represented in SLE clinical trials. We …

Jan 18, 2025 · Objectives Even in a lupus low disease activity state (LLDAS), many patients with SLE continue to face residual symptoms and disease burden. We aimed to evaluate the …

Sep 5, 2024 · Hemophagocytic lymphohistiocytosis (HLH) is a well-recognised complication of systemic lupus erythematosus (SLE). In one small case series, HLH was noted in …

Hunnicuttfi, et≤al Lupus Science Medicine 202411e001206 doi101136lupus-2024-001206 1 Patients achieving low lupus disease activity state, systemic lupus erythematosus disease …

Nordmann-GomesfiA, etfial Lupus Science Medicine 202411:e001331 doi:101136lupus-2024-001331 1 Lupus nephritis randomised controlled trials: evidence gaps and under- represented …

Oct 25, 2018 · Several patterns of hair loss can occur in lupus erythematosus (LE). Alopecias which show histological characteristics of LE are LE-specific, and include discoid LE (DLE), …